摘要:
This invention relates to a novel crystalline solid of carvedilol or a solvate thereof, to processes for its preparation, to compositions containing it and to its use in medicine. This invention further relates to a novel process for preparing a crystalline solid of carvedilol Form II.
摘要:
This invention relates to an improved process of preparing carvedilol, as well as a new crystalline hydrate and solvate and forms of carvedilol, processes for the manufacture thereof, and pharmaceutical compositions thereof.
摘要:
The invention encompasses amorphous montelukast sodium having less than about 50 ppm heptane or less than about 100 ppm hexane, less than about 150 ppm toluene, and less than about 2500 ppm C1-C5 alcohols, as well as processes for its preparation.
摘要翻译:本发明包括具有小于约50ppm庚烷或小于约100ppm己烷,小于约150ppm甲苯和小于约2500ppm C 1 -C 5的非晶孟鲁司特钠, 醇,以及其制备方法。